Home › Free Stock Grades › CLPT
ClearPoint Neuro, Inc. (CLPT) Stock Grade
CLPT · Healthcare
C
Market Cap
$459.1M
P/E Ratio
—
Revenue Growth (YoY)
+17.8%
Net Margin
-69.1%
Return on Equity
—
Dividend Yield
None
About ClearPoint Neuro, Inc.'s fundamentals
ClearPoint Neuro is a medical device company with a market capitalization of $459.1 million that has demonstrated solid revenue growth of 17.8% year-over-year, indicating expanding business activity. However, the company is currently unprofitable, with a net margin of -69.1% and a reported net loss in its latest annual statement, meaning it is spending significantly more than it generates in revenue. The company does not pay a dividend, which is typical for loss-making businesses that must retain capital for operations and growth.